AlloVir, Inc.
ALVR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $48 | $70 | $389 | $803 |
| - Cash | $118 | $90 | $106 | $202 |
| + Debt | $0 | $27 | $35 | $30 |
| Enterprise Value | -$70 | $7 | $318 | $632 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$3 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$65 | -$190 | -$166 | -$170 |
| % Margin | – | – | – | – |
| Net Income | -$59 | -$190 | -$169 | -$172 |
| % Margin | – | – | – | – |
| EPS Diluted | -11.73 | -42.09 | -50.6 | -63.02 |
| % Growth | 72.1% | 16.8% | 19.7% | – |
| Operating Cash Flow | -$68 | -$124 | -$142 | -$106 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$68 | -$124 | -$142 | -$106 |